Clinical Study for Patients With Hypertension Associated With Dyslipidemia

NCT01764295 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemia

Interventions

DRUG: DWJ1276
DRUG: Olmesartan
DRUG: Rosuvastatin
DRUG: Placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.